{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 83286200, "bookValue": -0.01, "fiftyDayAverage": 0.13184, "fiftyDayAverageChange": 0.015159994, "fiftyDayAverageChangePercent": 0.11498781, "twoHundredDayAverage": 0.13569, "twoHundredDayAverageChange": 0.011309996, "twoHundredDayAverageChangePercent": 0.08335173, "marketCap": 13603629, "priceToBook": -14.700001, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Biomark Diagnostics Inc", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "CAD", "regularMarketOpen": 0.146, "averageDailyVolume3Month": 84, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.045999996, "fiftyTwoWeekLowChangePercent": 0.4554455, "fiftyTwoWeekRange": "0.101 - 0.228", "fiftyTwoWeekHighChange": -0.081, "fiftyTwoWeekHighChangePercent": -0.35526317, "fiftyTwoWeekLow": 0.101, "fiftyTwoWeekHigh": 0.228, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1416985200000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": -0.003000006, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.147, "regularMarketDayRange": "0.146 - 0.147", "regularMarketDayLow": 0.146, "regularMarketVolume": 5000, "regularMarketPreviousClose": 0.15, "bid": 0.0, "ask": 0.0, "bidSize": 36000, "askSize": 19000, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": -2.000004, "regularMarketPrice": 0.147, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "BIOMARK DIAGNOSTICS INC.", "longName": "BioMark Diagnostics Inc.", "messageBoardId": "finmb_276547538", "market": "dr_market", "symbol": "20B.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3851 Shell Road", "address2": "Suite 130", "city": "Richmond", "state": "BC", "zip": "V6X 2W2", "country": "Canada", "phone": "604 370 0779", "website": "https://www.biomarkdiagnostics.com", "industry": "Diagnostics & Research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Rashid Ahmed Maula Bux B.Sc., MBA", "title": "Founder, CEO, Pres & Director", "fiscalYear": 2022, "totalPay": {"raw": 179460, "fmt": "179.46k", "longFmt": "179,460"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Guoyu  Huang MBA", "title": "Chief Financial Officer", "fiscalYear": 2022, "totalPay": {"raw": 74924, "fmt": "74.92k", "longFmt": "74,924"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brian Kai-Ming Cheng B.Sc., M.Sc, M.Sc.", "title": "Chief Technical Officer & Independent Director", "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jeff  Haince Ph.D.", "title": "GM & Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}